RxDoctor Payments Data

John Walch

Nurse Practitioner · Linwood, NJNPI 1457073454

Payments from drug & device makers

$3,089in general payments, 2019–2025

Across 151 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$724
  • GSK$428
  • Mylan Specialty L.p.$323
  • Philips North America LLC$239
  • Insmed, Inc.$212
  • Actelion Pharmaceuticals US, Inc.$165
  • plus $998 from 20 others

What the payments were for

  • Food & beverage$3,07099%
  • Education$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,089 in reported general payments places this provider in the 90th percentile of 2,138 nurse practitioner providers in New Jersey.

See all nurse practitioner providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter123$88,652
Breztri AerosphereBudesonide/Glycopyr/Formoterol61$42,399
Breo ElliptaFluticasone/Vilanterol18$6,821
EliquisApixaban11$6,100
Albuterol Sulfate HfaAlbuterol Sulfate110$4,251
Roflumilast53$4,005
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,598
Gabapentin15$1,998
Pantoprazole Sodium50$1,489
Fluticasone Propionate63$1,443
Azithromycin69$804
Montelukast Sodium40$656
Azelastine Hcl14$433
Prednisone118$405
Clonazepam33$363

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$428$95,473141 claims
AstraZenecaBreztri Aerosphere$724$42,39961 claims
PfizerEliquis$22$6,10011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,138 nurse practitioner providers in New Jersey.

Other nurse practitioner in Linwood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →